Therapeutic inertia

Darricarrere, C., Jacquot, E., Bricout, S., Louis, C., Bénard, M., & Poulter, N. R. (2023). Uncontrolled blood pressure and therapeutic inertia in treated hypertensive patients: A retrospective cohort study using a UK general practice database. J Clin Hypertens (Greenwich), 25, 895-904. http://doi.org/10.1111/jch.14699

View

Shabnam, S., Gillies, C. L., Davies, M. J., Dex, T., Melson, E., Khunti, K., et al. (2023). Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulin. Diabetes Res Clin Pract, 203, 110888. http://doi.org/10.1016/j.diabres.2023.110888

View

von Arx, L. B., Rachman, J., Webb, J., Casey, C., Patel, A., Diomatari, C., et al. (2023). Therapeutic inertia related to the injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.14985

View